Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 237   

Articles published

SNY 45.49 +0.27 (0.60%)
price chart
Sanofi CEO Ousted; Stock Price Tumbles
Sanofi SA (ADR)'s (SNY) stock price took a hit in yesterday's trading session as investors expressed disapproval over the decision by the company's board of directors to oust the now ex-CEO Chris Viehbacher from his position.
Related articles »  
Sanofi Expected To Report Moderate Earnings Growth For Q3
Sanofi SA (ADR) (SNY) will report financial and operational results for the third quarter of its 2014 fiscal year (3QFY14) on Tuesday, October 28 before the opening bell at the Euronext Paris stock exchange.
Buzz Stocks: Orbital Sciences Corp, Sanofi SA (ADR), and American Realty ...
Futures are little changed this morning, as investors await this afternoon's policy statement from the Federal Open Market Committee (FOMC).
Is Now A Good Time To Sell Sanofi SA (ADR) (NYSE:SNY), 2 Others? � National ...  Markets Emerging
Sanofi SA (ADR) (NYSE:SNY) Fires Its Chief Executive Post The Release Of ...  USMarketsDaily (blog)
Related articles »  
Healthcare Stocks with Major Changes- Sanofi SA (ADR) (NYSE:SNY), Eli Lilly ...
Sanofi SA (ADR) (NYSE:SNY) ousted its CEO recently, approaching its stock declined rapidly for the second day consecutively and showing a swing of downgrades on Wall Street.
Related articles »  
Hot Stocks: Sanofi SA (ADR) (NYSE:SNY), Pfizer Inc. (NYSE:PFE ...
The stalled effort of Sanofi SA (ADR) (NYSE:SNY) to sell its $8 billion drug portfolio happens to be the latest example of how the company's Chief Executive Officer Chris Viehbacher is functioning even without informing the board members.
Stocks Worth Adding To Your Watchlist: Sanofi SA (ADR) (NYSE:SNY), The ...
Sanofi SA (ADR) (NYSE:SNY) plunged 5.93% to new low on heavy volume as Chief Executive Christopher Viehbacher departed after the board voted to oust him.
Related articles »  
News on Boom: JPMorgan Chase & Co. (NYSE:JPM), Sanofi SA (ADR) (NYSE ...
Sanofi SA (ADR) (NYSE:SNY) vaccines separation, Sanofi Pasteur, declared the starting of a phase III clinical trial in India for its trial rotavirus vaccine, developed and making by its associate Shantha Biotechnics in Hyderabad, India.
Sanofi Responds To Bribery Allegations
Sanofi SA (ADR) (SNY) responded to allegations of bribery activity in the Middle East and Africa late Monday, stating that it has notified relevant US authorities about the issue and is conducting a private investigation into the matter.
Related articles »  
Notable Movers � Sanofi SA (ADR) (NYSE:SNY), Taiwan Semiconductor Mfg ...
Manhattan, NY- Thursday, October 30, 2014 - (Techsonian) �Sanofi SA (ADR) (NYSE:SNY) reported that detailed positive results from four Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia.
Related articles »  
Dengue Outbreak Hits China; Sanofi In Lead For Cure
(ADR) (FUJIY) to step forward with their respective anti-Ebola treatment therapies. The Ebola outbreak has claimed about 3,500 lives as of October 8. This might have brought out the pharmaceutical industry's human side.
Related articles »